Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 72

Learn how a VKORC1 genetic test predicts warfarin sensitivity, what G/G, G/A, and A/A results mean, and why dosing still requires CYP2C9 data and INR monitoring.

VKORC1 Genetic Test: Warfarin Sensitivity, Dose, and Results

Understand how a warfarin pharmacogenetic test uses CYP2C9, VKORC1, CYP4F2, and ancestry-aware results to estimate dose while INR monitoring guides safe treatment.

Warfarin Pharmacogenetic Test: CYP2C9, VKORC1, CYP4F2, Dose, and Results

Understand Alzheimer disease genetic testing for APOE, APP, PSEN1, and PSEN2, including who should test, result meanings, family risk, and treatment safety.

Alzheimer Disease Genetic Test: APOE, APP, PSEN1, PSEN2, and Results

Learn how ALS genetic testing evaluates C9orf72, SOD1, TARDBP, FUS, and other genes, what results mean, and how findings can affect treatment and family risk.

Amyotrophic Lateral Sclerosis (ALS) Genetic Test: C9orf72, SOD1, TARDBP, and Results

Understand Angelman syndrome genetic testing for UBE3A, methylation, deletions, uniparental disomy, and imprinting defects, including results and recurrence risk.

Angelman Syndrome Genetic Test: UBE3A, Methylation, Deletion, and Results

Learn what an APOE genotype test shows about Alzheimer disease risk, cholesterol disorders, anti-amyloid treatment safety, and ε2, ε3, and ε4 results.

APOE Genotype Test: Alzheimer Disease Risk, Cholesterol, and Results

Learn how chromosomal microarray, exome sequencing, genome sequencing, and targeted tests are used in autism, what results mean, and how findings may guide care.

Autism Genetic Testing: Chromosomal Microarray, Exome Sequencing, and Results

Learn how Becker muscular dystrophy genetic testing detects DMD deletions, duplications, and sequence variants, and what results mean for weakness, heart care, and family risk.

Becker Muscular Dystrophy Genetic Test: DMD Gene, Muscle Weakness, and Results

Understand how C9orf72 repeat expansion testing relates to ALS and frontotemporal dementia, how results are classified, and what they mean for family risk.

C9orf72 Genetic Test: ALS, Frontotemporal Dementia, and Results

Learn how Charcot-Marie-Tooth genetic testing evaluates PMP22, GJB1, MFN2, MPZ, copy-number changes, inheritance, and positive, negative, or uncertain results.

Charcot-Marie-Tooth Disease Genetic Test: PMP22, GJB1, MFN2, MPZ, and Results

Understand congenital myasthenic syndrome genetic panels, neuromuscular junction genes, result categories, inheritance, and why the exact subtype can change treatment.

Congenital Myasthenic Syndrome Genetic Test: Neuromuscular Junction Genes and Results

Understand CYP2D6 and CYP2C19 antidepressant pharmacogenetic results, metabolizer phenotypes, drug interactions, dosing implications, and test limitations.

CYP2D6 and CYP2C19 Psychiatric Medication Pharmacogenetic Test: Antidepressant Results

Learn how developmental delay genetic testing uses microarray, exome, genome, Fragile X, and targeted tests, and how to interpret positive, negative, and uncertain results.

Developmental Delay Genetic Test: DNA Variants, Diagnosis, and Results

Understand SCN1A genetic testing for Dravet syndrome, including who should be tested, variant results, treatment implications, inheritance, mosaicism, and negative tests.

Dravet Syndrome Genetic Test: SCN1A Gene Mutations and Results

Understand DMD genetic testing for Duchenne muscular dystrophy, including exon deletions, duplications, sequencing, reading-frame results, treatment eligibility, and carrier risk.

Duchenne Muscular Dystrophy Genetic Test: DMD Gene, Deletions, and Results

Learn how epilepsy genetic panel testing evaluates seizure genes, who benefits, how to interpret positive, uncertain, and negative results, and when findings can guide treatment.

Epilepsy Genetic Panel Test: Seizure Genes, Diagnosis, and Results

1...717273...137 Page 72 of 137